CoChat

Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity

Open access
Sauerberg, Per, Pettersson, Ingrid, Jeppesen, Lone, Bury, Paul S., Mogensen, John P., Wassermann, Karsten, Brand, Christian L., Sturis, Jeppe, Wöldike, Helle F., Fleckner, Jan, Andersen, Anne-Sofie T., Mortensen, Steen B., Svensson, L. Anders, Rasmussen, Hanne B., Lehmann, Søren V., Polivka, Zdenek, Sindelar, Karel, Panajotova, Vladimira, Ynddal, Lars, Wulff, Erik M. · 2002 · Journal of Medicinal Chemistry
Cited by 142

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Synthesis and structure-activity relationships of tricyclic alpha-ethoxy-phenylpropionic acid derivatives guided by in vitro PPARalpha and PPARgamma transactivation data and computer modeling led to the identification of the novel carbazole analogue, 3q, with dual PPARalpha (EC(50) = 0.36 microM) and PPARgamma (EC(50) = 0.17 microM) activity in vitro. Ten days treatment of db/db mice with 3q improved the insulin sensitivity, as measured by OGTT, better than that seen with both pioglitazone and rosiglitazone treatment, suggesting in vivo PPARgamma activity. Likewise, 3q lowered plasma triglycerides and cholesterol in high cholesterol fed rats after 4 days treatment, indicating in vivo PPARalpha activity. Investigations of the pharmacokinetics of selected compounds suggested that extended drug exposure improved the in vivo activity of in vitro active compounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm010964g

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 142

Metadata

Authors
Sauerberg, P., Pettersson, I., Jeppesen, L., Bury, P. S., Mogensen, J. P., Wassermann, K., Brand, C. L., Sturis, J., Wöldike, H. F., Fleckner, J., Andersen, A.-S. T., Mortensen, S. B., Svensson, L. A., Rasmussen, H. B., Lehmann, S. V., Polivka, Z., Sindelar, K., Panajotova, V., Ynddal, L., & Wulff, E. M.
Venue
Journal of Medicinal Chemistry
Published
2002-01-23
Volume
45
Issue
4
Pages
789-804
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W36311596
Cited by
142
References
3
FWCI
5.83
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity. https://app.cochat.ai/papers/10.1021/jm010964g
The paper
Sauerberg, P., Pettersson, I., Jeppesen, L., Bury, P. S., Mogensen, J. P., Wassermann, K., Brand, C. L., Sturis, J., Wöldike, H. F., Fleckner, J., Andersen, A.-S. T., Mortensen, S. B., Svensson, L. A., Rasmussen, H. B., Lehmann, S. V., Polivka, Z., Sindelar, K., Panajotova, V., Ynddal, L., & Wulff, E. M. (2002). Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm010964g

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.